3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
9
Sarcoma
4
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Myelodysplastic Syndromes
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
etoposide phosphate
1
cc-486
1
Sirolimus
1
Quality of Life
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Panitumumab
1
Molecular Diagnostic Techniques
1
Megestrol Acetate
1
Injections
1
Immunotherapy
1
IFL protocol
1
Gemcitabine
1
Fentanyl
1
Etoposide
1
Drug Therapy
1
Cyproheptadine
1
Cyclophosphamide
1
Cetuximab
1
Celecoxib
1
Biological Therapy
1
Azacitidine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
etoposide phosphate
×
Myeloid
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled